PRS CodeMatrix©: INLEXZO™ (gemcitabine intravesical system)
Download the INLEXZO™ CodeMatrix©
Access a practical PRS reimbursement tool designed to help practices understand coding, documentation, billing, access, and payer considerations related to INLEXZO™ (gemcitabine intravesical system).
Current Version: Q4 2026
Download INLEXZO™ CodeMatrix©
Preview of the INLEXZO™ PRS CodeMatrix© guidance document.
What’s Included
- HCPCS Level II product coding, including J9183
- NDC reporting considerations for INLEXZO™
- Procedure coding considerations for insertion and removal
- Physician office, hospital outpatient, and ASC billing considerations
- Documentation guidance for reimbursement support
- Prior authorization, access, acquisition, and payer-specific workflow notes
- Common coding and claim submission pitfalls
Designed For
- Urologists
- Advanced Practice Providers
- Billing and coding teams
- Practice administrators
- Revenue cycle leadership
- Hospital outpatient and ASC revenue integrity teams
PRS Perspective
INLEXZO™ coding and reimbursement workflows require alignment among product coding, NDC reporting, procedure documentation, site-of-care requirements, acquisition pathway, prior authorization, and payer-specific claim rules. PRS CodeMatrix© tools are designed to help practices evaluate, document, code, bill, and operationalize emerging technologies and services with greater reimbursement clarity.
